PortfoliosLab logo

Acurx Pharmaceuticals, Inc. (ACXP)

Equity · Currency in USD · Last updated Dec 7, 2022

Company Info

ISINUS00510M1045
CUSIP00510M104
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$3.30
Year Range$2.42 - $4.78
EMA (50)$3.18
EMA (200)$3.56
Average Volume$18.46K
Market Capitalization$38.26M

ACXPShare Price Chart


Loading data...

ACXPPerformance

The chart shows the growth of $10,000 invested in Acurx Pharmaceuticals, Inc. in Jun 2021 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $5,750 for a total return of roughly -42.50%. All prices are adjusted for splits and dividends.


-20.00%0.00%20.00%40.00%60.00%JulyAugustSeptemberOctoberNovemberDecember
12.75%
-1.90%
ACXP (Acurx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ACXPCompare to other instruments

Search for stocks, ETFs, and funds to compare with ACXP

ACXPReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
1M16.55%4.53%
6M27.78%-4.37%
YTD-20.16%-17.31%
1Y-16.87%-13.16%
5Y-31.68%-5.31%
10Y-31.68%-5.31%

ACXPMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2022-3.73%-12.52%-9.87%13.72%-27.88%40.89%-5.54%-2.51%-14.04%2.67%3.57%8.15%
20216.33%-10.97%-8.98%-0.58%-2.72%-4.00%-9.98%

ACXPSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Acurx Pharmaceuticals, Inc. Sharpe ratio is -0.28. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.200.000.20JulyAugustSeptemberOctoberNovemberDecember
-0.28
-0.59
ACXP (Acurx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ACXPDividend History


Acurx Pharmaceuticals, Inc. doesn't pay dividends

ACXPDrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%2022FebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember
-56.27%
-17.83%
ACXP (Acurx Pharmaceuticals, Inc.)
Benchmark (^GSPC)

ACXPWorst Drawdowns

The table below shows the maximum drawdowns of the Acurx Pharmaceuticals, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Acurx Pharmaceuticals, Inc. is 69.33%, recorded on May 24, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-69.33%Jun 28, 2021230May 24, 2022

ACXPVolatility Chart

Current Acurx Pharmaceuticals, Inc. volatility is 57.48%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%120.00%JulyAugustSeptemberOctoberNovemberDecember
57.48%
23.28%
ACXP (Acurx Pharmaceuticals, Inc.)
Benchmark (^GSPC)